铒玻璃1540nm点阵激光治疗面部瘢痕的疗效观察

Evaluation of non-ablative 1540nm fractional erbium-glass laser for facial scars treatment

目的:评估Lux 1540nm铒玻璃点阵激光治疗面部瘢痕的临床疗效。方法:面部瘢痕患者60例,接受1 540nmnm铒玻璃点阵激光治疗,每隔4周治疗1次,共治疗4次,评估治疗后疗效和不良反应。结果:60例患者中痊愈14例(23.33%),显效27例(45.00%),有效12例(20.00%),无效7例(11.67%),总有效率88.33%。不良反应为治疗即刻疼痛、红斑、水肿、炎症后色素沉着。结论:Lux 1 540nm铒玻璃点阵激光治疗面部瘢痕安全、有效。

Objective To evaluate the effective of non-ablative 1 540rim fractional erbium-glass laser for various types of facial scars treatment. Methods 60 cases of patients with facial scarring and were treated using a non-ablative 1 540nm fractional laser. Each patient was treated four times at 4 week interval, using the same parameters. Then assess the effect and adverse reactions after treatment. Results 14 of 60 cases were recovered （23.33%）,27 cases were improved markedly （45.00%）,12 cases were effective （20.00%）,7 cases were ineffective （11.67%）,the total effective rate was 88.33%. Adverse reactions include immediate pain,erythema,edema, pigmentation. Conclusion Treatment of Lux 1 540nm fractional erbium-glass laser for facial scar is safe and effective.